A lower starting dose of eltrombopag is efficacious in Japanese patients with previously treated chronic immune thrombocytopenia

Yoshiaki Tomiyama, Yoshitaka Miyakawa, Shinichiro Okamoto, +11

Journal of Thrombosis and Haemostasis

ThrombopoiesisThrombosisVenous ThrombosisAutoimmune DiseaseBlood Platelet +10

Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial

Catherine M. Broome, Vickie McDonald, Yoshitaka Miyakawa, +76

The Lancet

ThrombopoiesisAutoimmune DiseaseBlood PlateletPrimary Immune ThrombocytopeniaImmunology +9

Thrombospondin-bound Integrin-associated Protein (CD47) Physically and Functionally Modifies Integrin αIIbβ3 by Its Extracellular Domain

Tetsuro‐Takahiro Fujimoto, Shinya Katsutani, Takeshi Shimomura, +1

Journal of Biological Chemistry

A point mutation in glycoprotein IX coding sequence (Cys73 (TGT) to Tyr(TAT)) causes impaired surface expression of GPIb/IX/V complex in two families with Bernard-Soulier syndrome.

Masaaki Noda, Kingo Fujimura, Toshiro Takafuta, +9

PubMed

Transcriptional RegulationSystems BiologyEngineeringMendelian DisorderGenetic Disorder +13

Oligoclonal accumulation of T cells in peripheral blood from patients with idiopathic thrombocytopenic purpura

Takeshi Shimomura, Kingo Fujimura, Toshiro Takafuta, +5

British Journal of Haematology

Monoclonal antibody IAC-1 is specific for activated α2β1 and binds to amino acids 199 to 201 of the integrin α2 I-domain

Anne Schoolmeester, Karen Vanhoorelbeke, Shinya Katsutani, +5

Blood

A Point Mutation in Glycoprotein IX Coding Sequence (Cys73(TGT) to Tyr(TAT)) Causes Impaired Surface Expression of GPIb/IX/V Complex in Two Families with Bernard-Souiier Syndrome

Masaaki Noda, Kingo Fujimura, Toshiro Takafuta, +9

Thrombosis and Haemostasis

EngineeringGeneticsImmunodeficienciesMolecular BiologyPathology +20

Oral eltrombopag for up to three years is safe and well-tolerated in Japanese patients with previously treated chronic immune thrombocytopenia: an open-label, extension study

Shinya Katsutani, Yoshiaki Tomiyama, Akiro Kimura, +10

International Journal of Hematology

ThrombopoiesisThrombosisVenous ThrombosisAutoimmune DiseaseBlood Platelet +10

Hemodialysis together with peritoneal dialysis is one of the simplest ways to maintain adequacy in continuous ambulatory peritoneal dialysis.

Hideki Kawanishi, Misaki Moriishi, Shinya Katsutani, +2

PubMed

HemodialysisUrologyRenal DiseaseRenal FunctionPeritoneal Dialysis +12

Efficacy and safety of rituximab in Japanese patients with relapsed chronic immune thrombocytopenia refractory to conventional therapy

Yoshitaka Miyakawa, Shinya Katsutani, Takahiro Yano, +13

International Journal of Hematology

ThrombopoiesisThrombosisLymphoid NeoplasiaAutoimmune DiseaseSystemic Treatment +10